Current status and challenges of clinical research and development of new drugs for liver diseases
10.3760/cma.j.cn501113-20240227-00097
- VernacularTitle:肝病新药临床研发的现状和挑战
- Author:
Zhenyang SHEN
1
;
Xiaobo CAI
;
Lungen LU
Author Information
1. 上海交通大学医学院附属第一人民医院消化内科,上海 200080
- Keywords:
Liver disease;
New drugs;
Research and development
- From:
Chinese Journal of Hepatology
2024;32(4):289-294
- CountryChina
- Language:Chinese
-
Abstract:
Liver disease is a serious public health problem worldwide, affecting human health. However, there are still many unmet needs for the treatment of liver disease, especially with new therapeutic drugs. At present, there is no treatment method to eradicate the hepatitis B virus, nor are there therapeutic drugs for liver fibrosis, liver failure, and others. Chemotherapy and targeted immunotherapy are still unsatisfactory for liver cancer. This article provides an overview of the current status and challenges that arise in new drug research and development for liver diseases.